Conjugate vaccine for group b streptococcus

Details Conjugate vaccine for group b streptococcus Conjugate vaccine for group b streptococcus

C - Chemistry, Metallurgy

07

K

C07K 14/315 (2006.01) A61K 39/09 (2006.01) C12N 15/12 (2006.01)

Patent

CA 2383393

A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine is formed by conjugating a (a) a polysaccharide conjugated to (b) a protein; wherein both the polysaccharide and the protein are characteristic molecules of the group B Streptococcus.

Affiliated with

Also associated with

Rating

Conjugate vaccine for group b streptococcus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Conjugate vaccine for group b streptococcus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugate vaccine for group b streptococcus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1920894